The Bio Report
The Bio Report

Battling Zika and Other Diseases Like It

Concern about the spread of the Zika virus has sparked efforts to develop therapies and vaccines to counter it. But the outbreak reflects a growing threat from zoonetic diseases, once thought of as being contained to tropical regions, that are making incursions into the developed world. We spoke to

Featured Speakers

Levine Media Group HostJim Panucci Guest

Topics Discussed

Episode Summary

Executive Summary: The episode centers on Zika virus as an emerging public health threat and uses it to explore why mosquito-borne and other zoonotic diseases are increasingly relevant in the U.S. Jim Panucci of Southern Research explains Zika’s biology, its surprising sexual transmission route, the concern around microcephaly in pregnancy, and the lab and animal-model work needed to support vaccine development and testing. The discussion also broadens to surveillance, global preparedness, and funding priorities for outbreak response.

Main Topics: What Southern Research Does (Priority: 3/5): Panucci outlines Southern Research as a nonprofit contract research organization spanning drug discovery, drug development, energy/environment, and engineering, with infectious disease work housed in drug development. Zika Biology and Transmission (Priority: 5/5): The conversation explains that Zika is a mosquito-borne flavivirus with an additional sexual transmission pathway, making it more complex than many related viruses. Clinical Concern: Microcephaly and Neurologic Risk (Priority: 5/5): Although usually mild or asymptomatic, Zika is treated as dangerous because of associations with microcephaly in pregnancy and potential links to Guillain-Barré syndrome. Assays and Vaccine Evaluation (Priority: 4/5): Southern Research is developing plaque reduction neutralization assays to measure whether vaccine-induced antibodies can neutralize the virus in cell-based systems. Animal Model Development (Priority: 4/5): The organization is building macaque, rhesus macaque, and mouse models to characterize disease and translate findings toward human relevance. Why Tropical Diseases Are Emerging in the U.S. (Priority: 4/5): Panucci discusses ecological change, mosquito range shifts, and human travel as drivers of diseases such as West Nile, dengue, chikungunya, and Zika appearing in new regions. Surveillance, Communication, and Funding (Priority: 5/5): The interview concludes that sustained surveillance, rapid reporting, and coordinated investment are essential because outbreak threats compete with other public-health priorities for limited resources.

Key Arguments: Zika was historically considered relatively benign, but the microcephaly signal makes it a major public-health concern. The virus’s sexual transmission route increases its ability to spread beyond mosquito exposure alone. Even if an outbreak subsides, continued vaccine and therapeutic work is justified because future resurgence remains possible. Reliable animal models are essential because they allow researchers to compare toxicology, physiology, and molecular effects with human disease. Cell-based neutralization assays are a key tool for determining whether a vaccine is producing effective antibodies. Emerging zoonotic diseases are not confined to the tropics; ecology, vector adaptation, and travel can move them into the United States. Constant surveillance and communication are the best defenses against new outbreaks, especially when resources are limited.

Data Points: Southern Research main thrusts: 4 - Drug discovery, drug development, energy/environment, and engineering. Animal models under development: 3 - Macaque, rhesus macaque, and mouse models for Zika. Noted outbreak timing: Since the 1940s - Zika outbreaks have been recorded since the 1940s. Public health comparison viruses: 4 - Yellow fever, Japanese encephalitis virus, West Nile encephalitis virus, and Zika discussed as flaviviruses. Human health outcomes mentioned: Microcephaly and Guillain-Barré syndrome - Highlighted as major Zika-related complications.

Pivotal Quotes: "But this business with the microcephaly is very scary." — Jim Panucci: Explaining why Zika is now viewed as dangerous despite often mild symptoms. "I think the way to manage it, in my opinion, is to be very on top of surveillance and communication." — Jim Panucci: Describing the best strategy for responding to emerging infectious diseases. "Life finds a way." — Jim Panucci: Using a Jurassic Park reference to explain how diseases and species naturally migrate and adapt.

Implications: The episode argues that Zika-like threats require sustained research, better surveillance, and flexible public-health funding even after headlines fade. For industry and government, preparedness depends on assays, animal models, and coordinated global reporting.

🔓 Sign Up for Unlimited Episode Search

About The Bio Report

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

View all episodes from The Bio Report